Psilocybin trials for depression
35 recruiting now and 9 not yet recruiting, grouped by the conditions each study lists on ClinicalTrials.gov, read 28 October 2026. Recruiting trials are listed first.
- RecruitingEarly phase 1NCT04123314
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
Depressive Symptoms, Depression, Alzheimer Disease · Johns Hopkins University · Ages 18 to 85
Baltimore, Maryland, United States
- RecruitingPhase 2NCT06072898
A Randomized Neuroimaging Trial of Psilocybin in Depression
Depressive Disorder, Major Depressive Disorder · Sunnybrook Health Sciences Centre · Ages 18 to 64
Toronto, Ontario, Canada
- RecruitingPhase 2NCT06132178
Psilocybin rTMS for Treatment Resistant Depression
Treatment Resistant Depression, MDD, Major Depressive Disorder · University of Texas at Austin · Ages 22 to 65
Austin, Texas, United States
- RecruitingPhase 2NCT06200155
Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
Depression, Anxiety, Psilocybin-Assisted Psychotherapy, Advanced Cancer · M.D. Anderson Cancer Center · Ages 25+
Houston, Texas, United States
- RecruitingPhase 3NCT06247839
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
Major Depressive Disorder · Sharmin Ghaznavi · Ages 18 to 55
Charlestown, Massachusetts, United States
- RecruitingPhase 2NCT06319378
Cancer Related Major Depression Treated With a Single Dose of Psilocybin
MDD · Section for Affective Disorders; Northern Stockholm Psychiatry · Ages 20 to 80
4 sites in Sweden
- RecruitingPhase 1NCT06355414
Psilocybin in Chronic Low Back Pain and Depression
Chronic Low-back Pain, Depression · Johns Hopkins University · Ages 21 to 80
Baltimore, Maryland, United States
- RecruitingPhase 2NCT06378229
Psilocybin for Hospitalized Patients with Treatment-resistant Depression
Treatment Resistant Depression · University Hospital, Ghent · Ages 18+
Ghent, Oost-Vlaanderen, Belgium
- RecruitingPhase 1NCT06442423
Open-Label Psilocybin Study in Transdiagnostic Population
Transdiagnostic, Depression - Major Depressive Disorder, Anxiety · Yale University · Ages 18+
New Haven, Connecticut, United States
- RecruitingPhase 2NCT06455293
Psilocybin Therapy for Depression in Parkinson's Disease
Parkinson Disease, Depression · Joshua Woolley, MD, PhD · Ages 40 to 80
San Francisco, California, United States
- RecruitingPhase 2NCT06512194
Investigation to Understand and Optimize Psilocybin
Depression · Charles Raison · Ages 18 to 70
Edwards, Colorado, United States
- RecruitingPhase 2NCT06512220
Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)
Treatment Resistant Depression · Centre for Addiction and Mental Health · Ages 18 to 65
Toronto, Ontario, Canada
- RecruitingPhase 2NCT06518720
Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)
Treatment Resistant Depression, Chronic Pain · Centre for Addiction and Mental Health · Ages 18 to 65
Toronto, Ontario, Canada
- RecruitingPhase 2NCT06592833
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
Major Depressive Disorder · Icahn School of Medicine at Mount Sinai · Ages 21 to 80
New York, New York, United States
- RecruitingPhase 2NCT06706232
Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
Bipolar II Disorder, Depression, Bipolar, Suicidality · The University of Texas Health Science Center, Houston · Ages 25 to 70
Houston, Texas, United States
- RecruitingPhase 2NCT06782724
Psilocybin Therapy for Psychological Distress in Palliative Patients
COPD (Chronic Obstructive Pulmonary Disease), ALS (Amyotrophic Lateral Sclerosis), MS (Multiple Sclerosis) · University Medical Center Groningen · Ages 18+
4 sites in 4 countries
- RecruitingPhase 3NCT06793397
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Major Depressive Disorder (MDD), Depression in Adults, Depression - Major Depressive Disorder · Cybin IRL Limited · Ages 18 to 85
79 sites in 8 countries
- RecruitingPhase 2NCT06801041
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
Depression, Anxiety, Cancer · M.D. Anderson Cancer Center · Ages 18+
Houston, Texas, United States
- RecruitingPhase 2NCT06820723
A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety
Depression, Anxiety, Major Depressive Disorder · Ohio State University · Ages 21 to 65
Columbus, Ohio, United States
- RecruitingPhase 1 / Phase 2NCT06898606
Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression
Depressive Disorder · Federal University of Latin American Integration · Ages 25 to 65
Foz do Iguaçu, Paraná, Brazil
- RecruitingPhase 2NCT06899165
Psilocybin-Assisted Therapy for Intergenerational Trauma
Psychological Stress, Depression, Anxiety · Rachel Yehuda · Ages 18+
New York, New York, United States
- RecruitingPhase 2NCT06943573
Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder
Bipolar II Depression · Lakshmi N Yatham · Ages 19 to 65
3 sites in Canada (Vancouver, Ottawa, Toronto)
- RecruitingPhase 2NCT07104916
Mindfulness-based Psilocybin Therapy for PTSD
Post Traumatic Stress Disorder, Depression - Major Depressive Disorder · Anthony P King · Ages 21 to 65
Columbus, Ohio, United States
- RecruitingPhase 2NCT07183748
Psilocybin Microdosing With Psychotherapy for Treatment-Resistant Depression
Treatment Resistant Depression · Beersheva Mental Health Center · Ages 18 to 65
Beersheba, Israel
- RecruitingPhase 2NCT07210112
Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)
Depression - Major Depressive Disorder, Treatment-resistant Depression (TRD) · Centre Hospitalier St Anne · Ages 18+
Paris, France
- RecruitingPhase 2NCT07211438
Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression
Treatment-Resistant Depression · Centre for Addiction and Mental Health · Ages 18 to 70
2 sites in Canada (Toronto)
- RecruitingPhase 2NCT07216404
Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer
Lung Non-Small Cell Carcinoma, Unipolar Depression · Alan Davis · Ages 18+
Columbus, Ohio, United States
- RecruitingPhase 3NCT07226232
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
Major Depression · VA Office of Research and Development · Ages 18 to 75
5 sites in United States
- RecruitingPhase 1 / Phase 2NCT07251491
Psilocybin to Treat Depression in Spinal Cord Injury
Spinal Cord Injury, Depression - Major Depressive Disorder, Veteran · James J. Peters Veterans Affairs Medical Center · Ages 22+
The Bronx, New York, United States
- RecruitingPhase 1 / Phase 2NCT07281352
RCT of Psilocybin-assisted CBT for Depression
Major Depressive Diorder · University of California, Los Angeles · Ages 21 to 60
Los Angeles, California, United States
- RecruitingPhase 2NCT07405606
Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder
Major Depressive Disorder (MDD), Alcohol Use Disorder (AUD) · Centre for Addiction and Mental Health · Ages 18 to 65
Toronto, Ontario, Canada
- RecruitingPhase 1NCT07490353
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
Depression - Major Depressive Disorder, Anhedonia · Medical University of Vienna · Ages 18 to 55
Vienna, State of Vienna, Austria
- RecruitingPhase 2NCT07610369
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
Depression, Parkinson's Disease (PD) · Yale University · Ages 40 to 80
New Haven, Connecticut, United States
- RecruitingPhase 3NCT07638553
Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms
Alcohol Use Disorder, Depressive Sympotoms, Psilocybin · Centre Hospitalier Universitaire de Nīmes · Ages 18+
8 sites in France
- RecruitingPhase 3NCT07703722
Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Major Depressive Disorder
Major Depressive Disorder, Post-Traumatic Stress Disorder (PTSD) · Khyber Medical University Peshawar · Ages 18 to 60
3 sites in Pakistan (Islamabad, Peshawar)
- Not yet recruitingPhase 2NCT07373535
Understanding Music and Mindfulness Preferences in Psilocybin-Assisted Psychotherapy
Treatment-Resistant Major Depressive Disorder · Kyle Greenway · Ages 21+
2 sites in Canada (Montreal)
- Not yet recruitingPhase 2NCT07479550
Study of Psilocybin Under Anesthesia Controlled by EEG
Major Depression · Stanford University · Ages 25 to 65
Stanford, California, United States
- Not yet recruitingPhase 1 / Phase 2NCT07499583
Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder
Treatment Resistant Depression, Substance Use Disorders · Indiana University · Ages 18+
2 sites in United States (Indianapolis)
- Not yet recruitingPhase 2NCT07565909
Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression
Depression, Anxiety · University of Washington · Ages 25 to 70
Sites not yet listed
- Not yet recruitingPhase 2NCT07566104
Group PACBT for Depression
Depression - Major Depressive Disorder, Psilocybin, Cognitive Behavioral Therapy · University of California, Los Angeles · Ages 21 to 60
Los Angeles, California, United States
- Not yet recruitingPhase 2NCT07582120
Psilocybin-Assisted Therapy as a Treatment for Depression
Depression · Washington University School of Medicine · Ages 18+
St Louis, Missouri, United States
- Not yet recruitingPhase 2NCT07745569
Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
PTSD, PTSD - Post Traumatic Stress Disorder, Major Depression · University of New Mexico · Ages 18 to 69
Sites not yet listed
- Not yet recruitingPhase 1NCT07833761
ADEPT Psilocybin-Assisted Therapy With DBT for Borderline Personality Disorder
Borderline Personality Disorder, Borderline Personality Pathology, Depressive Symptoms · University of Minnesota · Ages 25 to 65
2 sites in United States (Minneapolis, Saint Louis Park)
- Not yet recruitingPhase 2NCT07895134
Psilocybin for Depression in Veterans
Major Depression · VA Office of Research and Development · Ages 18 to 70
4 sites in United States
How joining a trial works
- Free to take part
- Trials generally cost participants nothing for the study drug and the study visits, and some pay for travel or time. Check what a study covers on its registry page.
- Screened first
- Every study screens volunteers with questionnaires, medical history and often a physical and psychiatric check. Many people who apply are not enrolled.
- Eligibility is strict
- Common exclusions include a personal or family history of psychosis or bipolar disorder, some heart conditions, pregnancy and certain medications, which you may be asked to stop under medical supervision. Never stop a medication on your own to qualify.
- You may get a placebo
- Many trials compare psilocybin with a placebo or a low dose, and you may not be told which you had until the study ends.
- Contact the study team through the registry
- Each registry record lists the study contacts and sites. We do not republish personal emails or phone numbers; use the link on each trial page.
- Not medical advice
- This is a list of registry records, not a recommendation. Talk to your doctor before applying. Disclaimer · Safety and medications
Source: ClinicalTrials.gov API v2, U.S. National Library of Medicine, read 28 October 2026. Filter: overall status RECRUITING or NOT_YET_RECRUITING; an intervention named psilocybin, psilocin, COMP360 or CYB003. Refreshed weekly; a study's own registry page is always the current record.